A pharmaceutical company preparing for an upcoming drug launch needed to determine an optimal pricing and contracting strategy while anticipating payer coverage decisions. Twelve months before launch, the manufacturer partnered with MMIT to conduct custom pricing and contracting research using quantitative payer surveys and syndicated policy data. The study evaluated wholesale acquisition cost (WAC), rebate scenarios, payer perceptions of value, and anticipated formulary placement. By leveraging pricing analysis methodologies, including Van Westendorp Price Sensitivity Analysis, the company gained actionable insights to establish competitive pricing and appropriate rebates, helping maximize payer uptake and strengthen its market access strategy.